Author:
Charpentier Charlotte,Camacho Ricardo,Ruelle Jean,Kaiser Rolf,Eberle Josef,Gürtler Lutz,Pironti Alejandro,Stürmer Martin,Brun-Vézinet Françoise,Descamps Diane,Obermeier Martin
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Reference28 articles.
1. Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohort;Thiébaut;AIDS,2011
2. Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors;Ren;Proc Natl Acad Sci U S A,2002
3. Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis;Witvrouw;Antivir Ther,2004
4. Enfuvirtide, the first fusion inhibitor to treat HIV infection;Poveda;AIDS Rev,2005
5. In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors;Desbois;Antimicrob Agents Chemother,2008